Hepatic Impairment (HI)

Recruiting

A Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015)

NCT06442436

Conditions

Hepatic Impairment (HI)

Locations

• Clinical Pharmacology of Miami ( Site 0003) — Miami, Florida, United States
• Orlando Clinical Research Center ( Site 0001) — Orlando, Florida, United States
• Texas Liver Institute ( Site 0002) — San Antonio, Texas, United States

View Trial Details

Recruiting

A Pharmacokinetic Study of D-2570 in Participants With Hepatic Impairment and Normal Hepatic Function

NCT07715149

Conditions

Healthy Adult Participants, Hepatic Impairment (HI)

Locations

• The First Affiliated Hospital of Bengbu Medical University — Bengbu, Anhui, China

View Trial Details

Recruiting

A Study to Evaluate EDG-7500 in Adults With Hepatic Impairment

NCT07324616

Conditions

Hepatic Impairment (HI)

Locations

• The University of Miami Division of Clinical Pharmacology — Miami, Florida, United States
• Orlando Clinical Research Center — Orlando, Florida, United States

View Trial Details

Completed

A Varegacestat Hepatic Impairment Study

NCT06841315

Conditions

Healthy Volunteer, Hepatic Impairment (HI)

Locations

• Orlando Clinical Research Center — Orlando, Florida, United States
• The Texas Liver Institute — San Antonio, Texas, United States

View Trial Details